Showing results (21-30 of 481) with videos related to
Sort By:
Pageof 49
Journal of the American College of Cardiology|April 11, 2009
Interaction between cigarette smoking and clinical benefit of clopidogrelNihar R Desai, Jessica L Mega, Songtao Jiang, et al.European Heart Journal|November 11, 2008
Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35Marc S Sabatine, David A Morrow, James A de Lemos, et al.Journal of Thrombosis and Thrombolysis|February 15, 2011
Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysisShaheeda Ahmed, C Michael Gibson, Christopher P Cannon, et al.Journal of Thrombosis and Thrombolysis|February 27, 2007
Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28Dalton S McLean, Marc S Sabatine, Wei Guo, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2009
Identification of genetic variants associated with response to statin therapyJessica L Mega, David A Morrow, Alison Brown, et al.JAMA Cardiology|August 4, 2018
Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysisMarc S Sabatine, Stephen D Wiviott, KyungAh Im, et al.Nature Medicine|December 7, 2021
Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trialChristian T Ruff, Michelle Baron, KyungAh Im, et al.American Heart Journal|August 25, 2009
Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 TrialSean R Wilson, Marc S Sabatine, Eugene Braunwald, et al.The American Journal of Cardiology|September 18, 2004
Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS)David A Morrow, Marc S Sabatine, Elliott M Antman, et al.Journal of the American College of Cardiology|December 5, 2009
Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) SubstudyC Michael Gibson, Yuri B Pride, Claudia P Hochberg, et al.Pageof 49